Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-27T08:58:20.674Z Has data issue: false hasContentIssue false

Additive effects of a family history of schizophrenia spectrum disorders and an environmental risk score for the outcome of patients with non-affective first-episode psychosis

Published online by Cambridge University Press:  20 March 2024

Manuel J. Cuesta*
Affiliation:
Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
Elena García de Jalón
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
Ana M. Sánchez-Torres
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Departament of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain
Gustavo J. Gil-Berrozpe
Affiliation:
Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
Lidia Aranguren
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
Gerardo Gutierrez
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
Asier Corrales
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
Amalia Zarzuela
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
Berta Ibañez
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Methodology Unit, Navarrabiomed – HUN – UPNA, RICAPPS, Pamplona, Spain
Víctor Peralta
Affiliation:
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain Mental Health Department, Servicio Navarro de Salud – Osasunbidea, Pamplona, Spain
*
Corresponding author: Manuel J. Cuesta; Email: mcuestaz@cfnavarra.es

Abstract

Background:

First-episode psychotic disorders comprise a heterogeneous phenotype with a complex etiology involving numerous common small-effect genetic variations and a wide range of environmental exposures. We examined whether a family of schizophrenia spectrum disorder (FH-Sz) interacts with an environmental risk score (ERS-Sz) regarding the outcome of patients with non-affective first episode psychosis (NAFEP).

Methods:

We included 288 patients with NAFEP who were evaluated after discharge from an intensive 2-year program. We evaluated three outcome measures: symptomatic remission, psychosocial functioning, and personal recovery. We analyzed the main and joint associations of a FH-Sz and the ERS-Sz on the outcomes by using the relative excess risk due to interaction (RERI) approach.

Results:

A FH-Sz showed a significant association with poor symptomatic remission and psychosocial functioning outcomes, although there was no significant interaction between a FH-Sz and the ERS-Sz on these outcomes. The ERS-Sz did not show a significant association with poor symptomatic remission and psychosocial functioning outcomes, even though the magnitude of the interaction between ERS-Sz and FH-Sz with the later outcome was moderate (RERI = 6.89, 95% confidence interval −16.03 to 29.81). There was no association between a FH-Sz and the ERS-Sz and personal recovery.

Conclusions:

Our results provide further empirical support regarding the contribution of FH-Sz to poor symptomatic remission and poor psychosocial functioning outcomes in patients with NAFEP.

Type
Original Article
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

PEPsNa GROUP: Matilde Martínez, María Otero, Mari Cruz Ariz, Ainhoa Aquerreta, Leire Azcárate, Nahia Pereda, Fernando Monclús, Laura Moreno, Alba Fernández, Alba Sabaté, Izaskun Aguirre, Tadea Lizarbe, Myriam Ochoa Martínez and Maria Jose Begué.

References

Agerbo, E., Sullivan, P. F., Vilhjálmsson, B. J., Pedersen, C. B., Mors, O., Børglum, A. D., … Mortensen, P. B. (2015). Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia. JAMA Psychiatry, 72(7), 635. doi: 10.1001/jamapsychiatry.2015.0346CrossRefGoogle ScholarPubMed
Alem, A., Kebede, D., Fekadu, A., Shibre, T., Fekadu, D., Beyero, T., … Kullgren, G. (2009). Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia. Schizophrenia Bulletin, 35(3), 646654. doi: 10.1093/schbul/sbn029CrossRefGoogle Scholar
Ali, F., Sreeraj, V. S., Nadella, R. K., Holla, B., Mahadevan, J., Ithal, D., … Jain, S. (2021). Estimating the familial risk of psychiatric illnesses: A review of family history scores. Asian Journal of Psychiatry, 56, 102551. doi: 10.1016/j.ajp.2021.102551CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M., O'Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., … McGorry, P. D. (2016). Beyond clinical remission in first episode psychosis: Thoughts on antipsychotic maintenance vs. guided discontinuation in the functional recovery era. CNS Drugs, 30(5), 357368. doi: 10.1007/s40263-016-0331-xCrossRefGoogle ScholarPubMed
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005). Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry, 162(3), 441449. doi: 10.1176/appi.ajp.162.3.441CrossRefGoogle ScholarPubMed
Andreasen, N. C., Endicott, J., Spitzer, R. L., & Winokur, G. (1977). The family history method using diagnostic criteria: Reliability and validity. Archives of General Psychiatry, 34(10), 12291235. doi: 10.1001/archpsyc.1977.01770220111013CrossRefGoogle ScholarPubMed
Andreasen, N. C., Flaum, M., & Arndt, S. (1992). The Comprehensive Assessment of Symptoms and History (CASH): An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry, 49(8), 615623. doi: 10.1001/archpsyc.1992.01820080023004CrossRefGoogle ScholarPubMed
Andreassen, O. A., Hindley, G. F. L., Frei, O., & Smeland, O. B. (2023). New insights from the last decade of research in psychiatric genetics: Discoveries, challenges and clinical implications. World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 22(1), 424. doi: 10.1002/wps.21034CrossRefGoogle ScholarPubMed
Anthony, W. A. (1993). Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychosocial Rehabilitation Journal, 16(4), 11.CrossRefGoogle Scholar
Åsbø, G., Ueland, T., Haatveit, B., Bjella, T., Flaaten, C. B., Wold, K. F., … Simonsen, C. (2022). The time is ripe for a consensus definition of clinical recovery in first-episode psychosis: Suggestions based on a 10-year follow-up study. Schizophrenia Bulletin, 48(4), 839849. doi: 10.1093/schbul/sbac035CrossRefGoogle ScholarPubMed
Bigdeli, T. B., Ripke, S., Bacanu, S.-A., Lee, S. H., Wray, N. R., Gejman, P. V., … Schizophrenia Working Group of the Psychiatric Genomics, C. (2016). Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 171B(2), 276289. doi:10.1002/ajmg.b.32402CrossRefGoogle ScholarPubMed
Brasso, C., Giordano, B., Badino, C., Bellino, S., Bozzatello, P., Montemagni, C., & Rocca, P. (2021). Primary psychosis: Risk and protective factors and early detection of the onset. Diagnostics (Basel, Switzerland), 11(11), 2146. doi: 10.3390/diagnostics11112146Google ScholarPubMed
Bromet, E. J., Naz, B., Fochtmann, L. J., Carlson, G. A., & Tanenberg-Karant, M. (2005). Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. Schizophrenia Bulletin, 31(3), 639649. doi: 10.1093/schbul/sbi030CrossRefGoogle ScholarPubMed
Chang, W. C., Chan, T. C. W., Chen, E. S. M., Hui, C. L. M., Wong, G. H. Y., Chan, S. K. W., … Chen, E. Y. H. (2013). The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia. Schizophrenia Research, 143(1), 107115. doi: 10.1016/j.schres.2012.10.016CrossRefGoogle ScholarPubMed
Cowan, H. R., Lundin, N. B., Moe, A. M., & Breitborde, N. J. K. (2023). Discrepancies between self and caregiver perceptions of agency in first-episode psychosis. Journal of Psychiatric Research, 162, 220227. doi: 10.1016/j.jpsychires.2023.05.035CrossRefGoogle ScholarPubMed
Cuesta, M. J. (2023). Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology? European Neuropsychopharmacology, 73, 2123. doi: 10.1016/j.euroneuro.2023.04.016CrossRefGoogle ScholarPubMed
Cuesta, M. J., Papiol, S., Ibañez, B., García de Jalón, E., Sánchez-Torres, A. M., Gil-Berrozpe, G. J., … Peralta, V. (2023). Effect of polygenic risk score, family load of schizophrenia and exposome risk score, and their interactions, on the long-term outcome of first-episode psychosis. Psychological Medicine, 53(14), 68386847. doi: 10.1017/s0033291723000351CrossRefGoogle Scholar
Cuesta, M. J., Sánchez-Torres, A. M., Moreno-Izco, L., García de Jalón, E., Gil-Berrozpe, G. J., Zarzuela, A., … Zandio, M. (2022). Neurocognitive correlates of the varied domains of outcomes at 20 year follow-up of first-episode psychosis. Psychiatry Research, 318, 114933. doi: 10.1016/j.psychres.2022.114933CrossRefGoogle ScholarPubMed
Erzin, G., Pries, L.-K., Dimitrakopoulos, S., Ralli, I., Xenaki, L.-A., Soldatos, R.-F., … Stefanis, N. (2023). Association between exposome score for schizophrenia and functioning in first-episode psychosis: Results from the Athens first-episode psychosis research study. Psychological Medicine, 53(6), 26092618. doi: 10.1017/S0033291721004542CrossRefGoogle ScholarPubMed
Erzin, G., Pries, L.-K., van Os, J., Fusar-Poli, L., Delespaul, P., Kenis, G., … Guloksuz, S. (2021). Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European Psychiatry : the Journal of the Association of European Psychiatrists, 64(1), e25e25. doi: 10.1192/j.eurpsy.2021.19CrossRefGoogle ScholarPubMed
Esterberg, M., & Compton, M. (2012). Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients. Psychiatry Research, 197(1–2), 2328. doi: 10.1016/j.psychres.2012.03.001CrossRefGoogle ScholarPubMed
Esterberg, M. L., Trotman, H. D., Holtzman, C., Compton, M. T., & Walker, E. F. (2010). The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: A meta-analysis. Schizophrenia Research, 120(1–3), 121130. doi: 10.1016/j.schres.2010.01.011CrossRefGoogle ScholarPubMed
Feldmann, R., Hornung, W. P., Buchkremer, G., & Arolt, V. (2001). The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapy. Psychopathology, 34(4), 192197. doi: 10.1159/000049306CrossRefGoogle ScholarPubMed
Fusar-Poli, L., Rutten, B. P. F., van Os, J., Aguglia, E., & Guloksuz, S. (2022). Polygenic risk scores for predicting outcomes and treatment response in psychiatry: Hope or hype? International Review of Psychiatry, 34(7-8), 663675. doi: 10.1080/09540261.2022.2101352CrossRefGoogle ScholarPubMed
García de Jalón, E., Ariz, M. C., Aquerreta, A., Aranguren, L., Gutierrez, G., Corrales, A., … Cuesta, M. J. (2023). Effectiveness of the early intervention service for first-episode psychosis in navarra (PEPsNa): Broadening the scope of outcome measures. Spanish Journal of Psychiatry and Mental Health, 16(3), 192203. doi: 10.1016/j.rpsm.2022.07.002CrossRefGoogle Scholar
Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992). Revising axis V for DSM-IV: A review of measures of social functioning. American Journal of Psychiatry, 149(9), 11481156. doi: 10.1176/ajp.149.9.1148Google ScholarPubMed
Griffiths, S. L., & Birchwood, M. (2020). A synthetic literature review on the management of emerging treatment resistance in first episode psychosis: Can we move towards precision intervention and individualised care? Medicina (Kaunas, Lithuania), 56(12), 638. doi: 10.3390/medicina56120638CrossRefGoogle ScholarPubMed
Griffiths, S. L., Lalousis, P. A., Wood, S. J., & Upthegrove, R. (2022). Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: Does one size fit all? Translational Psychiatry, 12(1), 485485. doi: 10.1038/s41398-022-02256-7CrossRefGoogle ScholarPubMed
Guloksuz, S., Pries, L.-K., Delespaul, P., Kenis, G., Luykx, J. J., Lin, B. D., … van Os, J. (2019). Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: Results from the EUGEI study. World Psychiatry : official journal of the World Psychiatric Association (WPA), 18(2), 173182. doi: 10.1002/wps.20629CrossRefGoogle ScholarPubMed
Guloksuz, S., Rutten, B. P. F., Pries, L. K., Ten Have, M., de Graaf, R., van Dorsselaer, S., … Ioannidis, J. P. A. (2018). The complexities of evaluating the exposome in psychiatry: A data-driven illustration of challenges and some propositions for amendments. Schizophrenia Bulletin, 44(6), 11751179. doi: 10.1093/schbul/sby118CrossRefGoogle ScholarPubMed
Hansen, H. G., Starzer, M., Nilsson, S. F., Hjorthøj, C., Albert, N., & Nordentoft, M. (2023). Clinical recovery and long-term association of specialized early intervention services vs treatment as usual among individuals with first-episode schizophrenia spectrum disorder: 20-year follow-up of the OPUS trial. JAMA Psychiatry, 80(4), 371379. doi: 10.1001/jamapsychiatry.2022.5164CrossRefGoogle ScholarPubMed
Hegelstad, W. T. V., Larsen, T. K., Auestad, B., Evensen, J., Haahr, U., Joa, I., … McGlashan, T. (2012). Long-term follow-up of the TIPS early detection in psychosis study: Effects on 10-year outcome. American Journal of Psychiatry, 169(4), 374380. doi: 10.1176/appi.ajp.2011.11030459CrossRefGoogle ScholarPubMed
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. Jr (1984). The quality of life scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388398. doi: 10.1093/schbul/10.3.388CrossRefGoogle ScholarPubMed
Hosmer, D. W., & Lemeshow, S. (1992). Confidence interval estimation of interaction. Epidemiology (Cambridge, Mass.), 3(5), 452456. doi: 10.1097/00001648-199209000-00012CrossRefGoogle ScholarPubMed
Käkelä, J., Marttila, R., Keskinen, E., Veijola, J., Isohanni, M., Koivumaa-Honkanen, H., … Miettunen, J. (2017). Association between family history of psychiatric disorders and long-term outcome in schizophrenia – The northern Finland birth cohort 1966 study. Psychiatry Research, 249, 1622. doi: 10.1016/j.psychres.2016.12.040CrossRefGoogle ScholarPubMed
Käkelä, J., Panula, J., Oinas, E., Hirvonen, N., Jääskeläinen, E., & Miettunen, J. (2014). Family history of psychosis and social, occupational and global outcome in schizophrenia: A meta-analysis. Acta Psychiatrica Scandinavica, 130(4), 269278. doi: 10.1111/acps.12317CrossRefGoogle ScholarPubMed
Kendler, K. S., & Cloninger, C. R. (1987). Sporadic vs familial classification given etiologic heterogeneity: I. Sensitivity, specificity, and positive and negative predictive value. Genetic Epidemiology, 4(5), 313330. doi: 10.1002/gepi.1370040502CrossRefGoogle ScholarPubMed
Knol, M. J., & VanderWeele, T. J. (2012). Recommendations for presenting analyses of effect modification and interaction. International Journal of Epidemiology, 41(2), 514520. doi: 10.1093/ije/dyr218CrossRefGoogle ScholarPubMed
Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1(4), 208210. doi: 10.1159/000259089CrossRefGoogle Scholar
Lally, J., Ajnakina, O., Stubbs, B., Cullinane, M., Murphy, K. C., Gaughran, F., & Murray, R. M. (2017). Remission and recovery from first-episode psychosis in adults: Systematic review and meta-analysis of long-term outcome studies. British Journal of Psychiatry, 211(6), 350358. doi: 10.1192/bjp.bp.117.201475CrossRefGoogle ScholarPubMed
Lambert, M., Karow, A., Leucht, S., Schimmelmann, B. G., & Naber, D. (2010). Remission in schizophrenia: Validity, frequency, predictors, and patients' perspective 5 years later. Dialogues in Clinical Neuroscience, 12(3), 393407. doi: 10.31887/DCNS.2010.12.3/mlambertCrossRefGoogle ScholarPubMed
Landi, I., Kaji, D. A., Cotter, L., Van Vleck, T., Belbin, G., Preuss, M., … Charney, A. W. (2021). Prognostic value of polygenic risk scores for adults with psychosis. Nature Medicine, 27(9), 15761581. doi: 10.1038/s41591-021-01475-7CrossRefGoogle ScholarPubMed
Lewis, S. W., & Murray, R. M. (1987). Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. Journal of Psychiatric Research, 21(4), 413421. doi: 10.1016/0022-3956(87)90088-4CrossRefGoogle ScholarPubMed
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet (London, England), 373(9659), 234239. doi: 10.1016/S0140-6736(09)60072-6CrossRefGoogle ScholarPubMed
Lu, Y., Pouget, J. G., Andreassen, O. A., Djurovic, S., Esko, T., Hultman, C. M., … Sullivan, P. F. (2018). Genetic risk scores and family history as predictors of schizophrenia in Nordic registers. Psychological Medicine, 48(7), 12011208. doi: 10.1017/S0033291717002665CrossRefGoogle ScholarPubMed
Mas, S., Boloc, D., Rodríguez, N., Mezquida, G., Amoretti, S., Cuesta, M. J., … Group, P. E. (2020). Examining gene-environment interactions using aggregate scores in a first-episode psychosis cohort. Schizophrenia Bulletin, 46(4), 10191025. doi: 10.1093/schbul/sbaa012CrossRefGoogle Scholar
McLellan, A. T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H. L., & O'Brien, C. P. (1985). New data from the addiction severity index reliability and validity in three centers. The Journal of Nervous and Mental Disease, 173(7), 412423. Retrieved from https://journals.lww.com/jonmd/fulltext/1985/07000/new_data_from_the_addiction_severity_index.5.aspxCrossRefGoogle ScholarPubMed
Mortensen, P. B., Pedersen, C. B., Westergaard, T., Wohlfahrt, J., Ewald, H., Mors, O., … Melbye, M. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine, 340(8), 603608. doi: 10.1056/nejm199902253400803CrossRefGoogle ScholarPubMed
Mueser, K. T., Kim, M., Addington, J., McGurk, S. R., Pratt, S. I., & Addington, D. E. (2017). Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised. Schizophrenia Research, 181, 117123. doi: 10.1016/j.schres.2016.10.018CrossRefGoogle ScholarPubMed
O'Keeffe, D., Hannigan, A., Doyle, R., Kinsella, A., Sheridan, A., Kelly, A., … Clarke, M. (2019). The iHOPE-20 study: Relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis. Australian and New Zealand Journal of Psychiatry, 53(11), 10801092. doi: 10.1177/0004867419827648CrossRefGoogle ScholarPubMed
Peralta, V., García de Jalón, E., Moreno-Izco, L., Peralta, D., Janda, L., & Sánchez-Torres, A. M., … Group, S. E. (2022). Long-term outcomes of first-admission psychosis: A naturalistic 21-year follow-up study of symptomatic, functional and personal recovery and their baseline predictors. Schizophrenia Bulletin, 48(3), 631642. doi: 10.1093/schbul/sbab145CrossRefGoogle ScholarPubMed
Phahladira, L., Luckhoff, H. K., Asmal, L., Kilian, S., Scheffler, F., Plessis, S. D., … Emsley, R. (2020). Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders. NPJ schizophrenia, 6(1), 22. doi: 10.1038/s41537-019-0091-yCrossRefGoogle ScholarPubMed
Pries, L. K., Dal Ferro, G. A., van Os, J., Delespaul, P., Kenis, G., Lin, B. D., … Guloksuz, S. (2020). Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum. Epidemiology and Psychiatric Sciences, 29, e182e182. doi: 10.1017/S2045796020000943CrossRefGoogle ScholarPubMed
Pries, L.-K., Erzin, G., Rutten, B. P. F., van Os, J., & Guloksuz, S. (2021). Estimating aggregate environmental risk score in psychiatry: The exposome score for schizophrenia. Frontiers in psychiatry, 12, 671334671334. doi: 10.3389/fpsyt.2021.671334CrossRefGoogle ScholarPubMed
Pries, L.-K., Moore, T. M., Visoki, E., Sotelo, I., Barzilay, R., & Guloksuz, S. (2022). Estimating the association between exposome and psychosis as well as general psychopathology: Results from the ABCD study. Biological Psychiatry Global Open Science, 2(3), 283291. doi: 10.1016/j.bpsgos.2022.05.005CrossRefGoogle ScholarPubMed
Radua, J., Ramella-Cravaro, V., Ioannidis, J. P. A., Reichenberg, A., Phiphopthatsanee, N., Amir, T., … Fusar-Poli, P. (2018). What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 17(1), 4966. doi: 10.1002/wps.20490CrossRefGoogle ScholarPubMed
Ran, M.-S., Weng, X., Chan, C. L.-W., Chen, E. Y.-H., Tang, C.-P., Lin, F.-R., … Xiang, M.-Z. (2015). Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China. The British Journal of Psychiatry : the Journal of Mental Science, 207(6), 495500. doi: 10.1192/bjp.bp.114.157685CrossRefGoogle ScholarPubMed
Rey, J. M. (1997). A global scale to measure the quality of the family environment. Archives of General Psychiatry, 54(9), 817. doi: 10.1001/archpsyc.1997.01830210061006CrossRefGoogle ScholarPubMed
Richardson, D. B., & Kaufman, J. S. (2009). Estimation of the relative excess risk due to interaction and associated confidence bounds. American Journal of Epidemiology, 169(6), 756760. doi: 10.1093/aje/kwn411CrossRefGoogle ScholarPubMed
Santesteban-Echarri, O., Paino, M., Rice, S., González-Blanch, C., McGorry, P., Gleeson, J., & Alvarez-Jimenez, M. (2017). Predictors of functional recovery in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies. Clinical Psychology Review, 58, 5975. doi: 10.1016/j.cpr.2017.09.007CrossRefGoogle ScholarPubMed
Stapp, E. K., Mendelson, T., Merikangas, K. R., & Wilcox, H. C. (2020). Parental bipolar disorder, family environment, and offspring psychiatric disorders: A systematic review. Journal of Affective Disorders, 268, 6981. doi: 10.1016/j.jad.2020.03.005CrossRefGoogle ScholarPubMed
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Archives of General Psychiatry, 60(12), 11871192. doi: 10.1001/archpsyc.60.12.1187CrossRefGoogle ScholarPubMed
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., … Schizophrenia Working Group of the Psychiatric Genomics, C. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502508. doi: 10.1038/s41586-022-04434-5CrossRefGoogle ScholarPubMed
VanderWeele, T. J., Chen, Y., & Ahsan, H. (2011). Inference for causal interactions for continuous exposures under dichotomization. Biometrics, 67(4), 14141421. doi: 10.1111/j.1541-0420.2011.01629.xCrossRefGoogle ScholarPubMed
Van Eck, R. M., van Velden, J., Vellinga, A., van der Krieke, L., Castelein, S., van Amelsvoort, T., … Schirmbeck, F. (2023). Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls. Schizophrenia Research, 255, 2432. doi: 10.1016/j.schres.2023.02.026CrossRefGoogle ScholarPubMed
Vassos, E., Sham, P., Kempton, M., Trotta, A., Stilo, S. A., Gayer-Anderson, C., … Morgan, C. (2020). The Maudsley environmental risk score for psychosis. Psychological Medicine, 50(13), 22132220. doi: 10.1017/S0033291719002319CrossRefGoogle ScholarPubMed
Verdolini, N., Amoretti, S., Mezquida, G., Cuesta, M. J., Pina-Camacho, L., García-Rizo, C., … Bernardo, M. (2021). The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years. European Neuropsychopharmacology, 49, 5468. doi: 10.1016/j.euroneuro.2021.03.015CrossRefGoogle ScholarPubMed
Waszczuk, M. A., Jonas, K. G., Bornovalova, M., Breen, G., Bulik, C. M., Docherty, A. R., … Waldman, I. D. (2023). Dimensional and transdiagnostic phenotypes in psychiatric genome-wide association studies. Molecular Psychiatry. doi: 10.1038/s41380-023-02142-8CrossRefGoogle ScholarPubMed
Yang, J., Visscher, P. M., & Wray, N. R. (2010). Sporadic cases are the norm for complex disease. European Journal of Human Genetics : EJHG, 18(9), 10391043. doi: 10.1038/ejhg.2009.177CrossRefGoogle ScholarPubMed
Supplementary material: File

Cuesta et al. supplementary material 1

Cuesta et al. supplementary material
Download Cuesta et al. supplementary material 1(File)
File 145.1 KB
Supplementary material: File

Cuesta et al. supplementary material 2

Cuesta et al. supplementary material
Download Cuesta et al. supplementary material 2(File)
File 18.1 KB